Working… Menu
Trial record 34 of 53 for:    stem cell Spinal Cord Injury AND Nervous

Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury (ABMST-SCI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01186679
Recruitment Status : Completed
First Posted : August 23, 2010
Last Update Posted : August 23, 2010
Information provided by:
International Stemcell Services Limited

Brief Summary:

The projected data related to the burden of spinal cord injuries induced limb paralysis in India is quite alarming. This is attributed to the rapid industrialization and economical development in the country. Increase in vehicular traffic has caused numerous road traffic accidents. Rapid increase in populations, development in the computer technology and real estate business lead to construction of huge buildings which indirectly adds to the injuries due to fall. Spinal cord injuries could not be treated adequately with the prevailing treatment modalities. In view of this, there is definitely an urgent need for finding different methods of treatment for these patients who cannot undergo established modalities of treatment or these have been tried unsuccessfully. Since a large number of these patients will loose their productive life and at the prime of their lives, one such alternate therapy, which seems to offer some promise, is "stem cell" therapy, which has been well studied and published in prestigious journals.

In our present study, we want to evaluate the safety and efficacy of autologous bone marrow derived stem cells surgically transplanted directly into the lesion site with glial scar resection for 8 indian patients of chronic spinal cord injury and intra-thecal injection for 4 indian patients of acute and subacute injury.

Condition or disease Intervention/treatment Phase
Spinal Cord Injuries Procedure: laminectomy Procedure: Intrathecal Phase 1 Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Surgical Transplantation of Autologous Bone Marrow Stem Cells With Glial Scar Resection for Patients of Chronic Spinal Cord Injury and Intra-thecal Injection for Acute and Subacute Injury - A Preliminary Study
Study Start Date : January 2008
Actual Primary Completion Date : February 2010
Actual Study Completion Date : August 2010

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Intralesional
  1. Surgical transplantation into the lesion site in chronic patients
  2. Direct intrathecal implantation in acute and subacute patients
Procedure: laminectomy
surgical laminectomy with glial scar resection

Experimental: intrathecal
direct into the CSF through lumbar puncture
Procedure: Intrathecal
direct into the CSF through lumbar puncture

Primary Outcome Measures :
  1. Number of Participants with adverse events as a measure of safety and tolerability. Significant clinical improvement in ASIA impairment scale and general condition [ Time Frame: 18 months ]
    American Spinal Injury Assessment scale of A,B,C,D or E

Secondary Outcome Measures :
  1. Changes in the MRI, Neurological improvement (cranial/spinal reflexes) and evoked potentials study [ Time Frame: 18 months ]
    MRI findings of the lesion, Nerve conduction studies of the region and somatosensory evoked potentials of the same region

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   20 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Must be able to give voluntary (patients may not be able to write) consent.
  2. Must be able to understand study information provided to him.
  3. Patients with complete spinal cord trans-section: at least post 6 months after spinal cord Injury (in chronic patients), < 2 weeks in acute category and 2-8 weeks in subacute patients.
  4. The level of spinal cord injury must be between C4 and T12(neurological level)
  5. Spinal cord injury categorized in terms of ASIA Impairment scale.
  6. Age should be between 20-55 years

Exclusion Criteria:

  • Mechanical ventilation due to neurological impairment
  • Multiple level trauma
  • Undetermined size and location of Spinal Cord injury
  • Gunshot or other penetrating trauma to the spinal cord
  • Longitudinal dimension of injury by MRI is greater than 3spinal segments
  • Associated severe head injury
  • More than 9cms long bone fracture
  • Women who are pregnant or lactating
  • Serious pre-existing medical conditions
  • Disease or impairment that precludes adequate neurological examination.
  • Should not have co-morbidities like Diabetes, Systemic Hypertension etc.
  • Severe co-morbidities/bed sores Tests positive for infectious diseases Deranged Coagulation profile and Hb < 8mg/dl

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01186679

Layout table for location information
Sita Bhateja Speciality Hospital
Bangalore, Karnataka, India, 560025
Sponsors and Collaborators
International Stemcell Services Limited
Layout table for investigator information
Principal Investigator: Dr.Arvind Bhateja, MCh.Neurosurgery Sita Bhateja Speciality Hospital

Layout table for additonal information
Responsible Party: Dr.SGA.Rao, Chairman, International Stemcell Services Ltd. Identifier: NCT01186679     History of Changes
Other Study ID Numbers: ISSL-AuBM-SCI
First Posted: August 23, 2010    Key Record Dates
Last Update Posted: August 23, 2010
Last Verified: August 2010
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Wounds and Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System